DACLIRCO Trademark

Trademark Overview

On Thursday, February 14, 2013, a trademark application was filed for DACLIRCO with the United States Patent and Trademark Office. The USPTO has given the DACLIRCO trademark a serial number of 85850396. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 13, 2017. This trademark is owned by Bristol-Myers Squibb Company. The DACLIRCO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
daclirco

General Information

Serial Number85850396
Word MarkDACLIRCO
Filing DateThursday, February 14, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 13, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 22, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, March 13, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 13, 2017ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 5, 2016EXTENSION 5 GRANTED
Thursday, August 4, 2016EXTENSION 5 FILED
Thursday, August 4, 2016TEAS EXTENSION RECEIVED
Tuesday, February 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 6, 2016EXTENSION 4 GRANTED
Thursday, February 4, 2016EXTENSION 4 FILED
Thursday, February 4, 2016TEAS EXTENSION RECEIVED
Thursday, August 6, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2015EXTENSION 3 GRANTED
Tuesday, August 4, 2015EXTENSION 3 FILED
Tuesday, August 4, 2015TEAS EXTENSION RECEIVED
Saturday, February 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 6, 2015EXTENSION 2 GRANTED
Wednesday, February 4, 2015EXTENSION 2 FILED
Wednesday, February 4, 2015TEAS EXTENSION RECEIVED
Wednesday, August 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 26, 2014EXTENSION 1 GRANTED
Monday, August 4, 2014EXTENSION 1 FILED
Tuesday, August 26, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 4, 2014TEAS EXTENSION RECEIVED
Tuesday, February 4, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 6, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 6, 2013ASSIGNED TO LIE
Tuesday, October 22, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 18, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 18, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 18, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 16, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 16, 2013NON-FINAL ACTION E-MAILED
Thursday, May 16, 2013NON-FINAL ACTION WRITTEN
Tuesday, May 14, 2013ASSIGNED TO EXAMINER
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 22, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 18, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

daclirco diseases pharmaceutical human anti preparations disorders organ solid auto immune